Table 5 Modified SLEDAI scores in relation to occurrence of individual ANA specificities in sera and IC.
Serum | IC | |||||||
|---|---|---|---|---|---|---|---|---|
ANA | SLEDAI median in antibody neg/pos patients Sudan | P | SLEDAI median in antibody neg/pos patients Sweden | P | SLEDAI median in antibody neg/pos patients Sudan | P | SLEDAI median in antibody neg/pos patients Sweden | P |
SSA/Ro52 | 0/0 | 0.3 | 0/1 | 0.07 | 0/0 | 0.6 | 0/1 | 0.08 |
SSA/Ro60 | 0/0 | 0.2 | 0/1 | 0.007 | 0/0 | 0.5 | 0/1 | 0.02 |
SSB/La | 0/1 | 0.2 | 0/0 | 0.2 | 0/0 | 0.9 | 0/0 | 0.6 |
Sm | 0/3 | 0.0007 | 0/1 | 0.06 | 0/2 | 0.08 | 0/1 | 0.5 |
SmRNP | 0/2 | 0.004 | 0/1 | 0.1 | 0/0 | 0.2 | 0/1 | 0.08 |
U1RNP | 0/2 | 0.001 | 0/1 | 0.1 | 0/2 | 0.001 | 0/1 | 0.002 |
dsDNA | 0/0 | 0.1 | 0/0 | 0.2 | 0/0 | 0.7 | 0/1 | 0.02 |
Histone | 0/0 | 0.2 | 0/1 | 0.01 | 0/0 | 0.1 | 0/2 | < 0.0001 |
Ribosomal P | 0/2 | 0.3 | 0/1 | 0.1 | 0/0 | 0.3 | 0/0 | 0.9 |
PCNA | 0/0 | 0.5 | 0/1 | 0.2 | 0/0 | 0.8 | 0/1 | 0.06 |
